These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 23266512)

  • 1. Expression of glucose transporters in cancers.
    Szablewski L
    Biochim Biophys Acta; 2013 Apr; 1835(2):164-9. PubMed ID: 23266512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxic regulation of glucose transport, anaerobic metabolism and angiogenesis in cancer: novel pathways and targets for anticancer therapeutics.
    Airley RE; Mobasheri A
    Chemotherapy; 2007; 53(4):233-56. PubMed ID: 17595539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facilitative glucose transporters: Implications for cancer detection, prognosis and treatment.
    Barron CC; Bilan PJ; Tsakiridis T; Tsiani E
    Metabolism; 2016 Feb; 65(2):124-39. PubMed ID: 26773935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose transporter 1 expression, tumor proliferation, and iodine/glucose uptake in thyroid cancer with emphasis on poorly differentiated thyroid carcinoma.
    Grabellus F; Nagarajah J; Bockisch A; Schmid KW; Sheu SY
    Clin Nucl Med; 2012 Feb; 37(2):121-7. PubMed ID: 22228332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer.
    Macheda ML; Rogers S; Best JD
    J Cell Physiol; 2005 Mar; 202(3):654-62. PubMed ID: 15389572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reciprocal change in Glucose metabolism of Cancer and Immune Cells mediated by different Glucose Transporters predicts Immunotherapy response.
    Na KJ; Choi H; Oh HR; Kim YH; Lee SB; Jung YJ; Koh J; Park S; Lee HJ; Jeon YK; Chung DH; Paeng JC; Park IK; Kang CH; Cheon GJ; Kang KW; Lee DS; Kim YT
    Theranostics; 2020; 10(21):9579-9590. PubMed ID: 32863946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positherapy: targeted nuclear therapy of breast cancer with 18F-2-deoxy-2-fluoro-D-glucose.
    Moadel RM; Weldon RH; Katz EB; Lu P; Mani J; Stahl M; Blaufox MD; Pestell RG; Charron MJ; Dadachova E
    Cancer Res; 2005 Feb; 65(3):698-702. PubMed ID: 15705862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond.
    Ganapathy V; Thangaraju M; Prasad PD
    Pharmacol Ther; 2009 Jan; 121(1):29-40. PubMed ID: 18992769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of glucose transporter 1 (GLUT1) in the diagnosis and therapy of tumors].
    Jóźwiak P; Lipińska A
    Postepy Hig Med Dosw (Online); 2012 Jan; 66():165-74. PubMed ID: 22470192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of PPAR-gamma agonist on (18)F-FDG uptake in tumor and macrophages and tumor cells.
    Kim SL; Kim EM; Cheong SJ; Lee CM; Kim DW; Jeong HJ; Lim ST; Sohn MH; Yim CY
    Nucl Med Biol; 2009 May; 36(4):427-33. PubMed ID: 19423011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential subcellular distribution of glucose transporters GLUT1-6 and GLUT9 in human cancer: ultrastructural localization of GLUT1 and GLUT5 in breast tumor tissues.
    Godoy A; Ulloa V; Rodríguez F; Reinicke K; Yañez AJ; García Mde L; Medina RA; Carrasco M; Barberis S; Castro T; Martínez F; Koch X; Vera JC; Poblete MT; Figueroa CD; Peruzzo B; Pérez F; Nualart F
    J Cell Physiol; 2006 Jun; 207(3):614-27. PubMed ID: 16523487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-fluorodeoxyglucose positron emission tomography/computed tomography and the relationship between fluorodeoxyglucose uptake and the expression of hypoxia-inducible factor-1α, glucose transporter-1 and vascular endothelial growth factor in thymic epithelial tumours.
    Toba H; Kondo K; Sadohara Y; Otsuka H; Morimoto M; Kajiura K; Nakagawa Y; Yoshida M; Kawakami Y; Takizawa H; Kenzaki K; Sakiyama S; Bando Y; Tangoku A
    Eur J Cardiothorac Surg; 2013 Aug; 44(2):e105-12. PubMed ID: 23674658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of Glut-1 and increased glucose metabolism in tumors are associated with a poor prognosis in patients with oral squamous cell carcinoma.
    Kunkel M; Reichert TE; Benz P; Lehr HA; Jeong JH; Wieand S; Bartenstein P; Wagner W; Whiteside TL
    Cancer; 2003 Feb; 97(4):1015-24. PubMed ID: 12569601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose transporters in the thyroid.
    Matsuzu K; Segade F; Wong M; Clark OH; Perrier ND; Bowden DW
    Thyroid; 2005 Jun; 15(6):545-50. PubMed ID: 16029120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and regulation of glucose transporters in the bovine mammary gland.
    Zhao FQ; Keating AF
    J Dairy Sci; 2007 Jun; 90 Suppl 1():E76-86. PubMed ID: 17517754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of expression of the oncosuppressor PTEN in thyroid incidentalomas associates with GLUT1 plasmamembrane expression.
    Morani F; Pagano L; Prodam F; Aimaretti G; Isidoro C
    Panminerva Med; 2012 Jun; 54(2):59-63. PubMed ID: 22525560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical implication of glucose transport and metabolism evaluated by 18F-FDG PET in hepatocellular carcinoma.
    Paudyal B; Paudyal P; Oriuchi N; Tsushima Y; Nakajima T; Endo K
    Int J Oncol; 2008 Nov; 33(5):1047-54. PubMed ID: 18949368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncocytic carcinoid tumor of the lung with intense F-18 fluorodeoxyglucose (FDG) uptake in positron emission tomography-computed tomography (PET/CT).
    Tanabe Y; Sugawara Y; Nishimura R; Hosokawa K; Kajihara M; Shimizu T; Takahashi T; Sakai S; Sawada S; Yamashita M; Ohtani H
    Ann Nucl Med; 2013 Oct; 27(8):781-5. PubMed ID: 23757317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Glucose Transporters in Oral Squamous Cell Carcinoma.
    Botha H; Farah CS; Koo K; Cirillo N; McCullough M; Paolini R; Celentano A
    Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of glucose transporters in human pancreatic tumors compared with increased FDG accumulation in PET study.
    Higashi T; Tamaki N; Honda T; Torizuka T; Kimura T; Inokuma T; Ohshio G; Hosotani R; Imamura M; Konishi J
    J Nucl Med; 1997 Sep; 38(9):1337-44. PubMed ID: 9293783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.